Moldova -
Romania -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
incivo comprimate filmate 375 mg
johnson & johnson srl - comprimate filmate - 375 mg
Romania -
Romania -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
flixotide 125 inhaler cfc - free
glaxo wellcome uk ltd. - fluticasonum propionat - susp. inhal. presurizata - 125µg/doza - alte med. pt. trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi
Romania -
Romania -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
flixotide 250 inhaler cfc - free
glaxo wellcome uk ltd. - fluticasonum propionat - susp. inhal. presurizata - 250µg/doza - alte med. pt.trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi
Romania -
Romania -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
flixotide 50 inhaler cfc - free
glaxo wellcome uk ltd. - fluticasonum propionat - susp. inhal. presurizata - 50µg/doza - alte med. pt.trat.bolilor obstructive ale c.r, inhalatorii glucocorticoizi
Kesatuan Eropah -
Romania -
EMA (European Medicines Agency)
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.
Romania -
Romania -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
candesartan hct tchaikapharma 8 mg/12,5 mg
tchaikapharma high quality medicines inc. - combinatii (candesartanum cilexetil+hct) - compr. - 8mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic
Romania -
Romania -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
candesartan hct tchaikapharma 16 mg/12,5 mg
tchaikapharma high quality medicines inc. - combinatii (candesartanum cilexetil+hct) - compr. - 16mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic
Romania -
Romania -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rosuvastatina tchaikapharma 40 mg
tchaikapharma high quality medicines inc. - rosuvastatinum - compr. film. - 40mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei